An Open Label pH Comparison of Esomeprazole and Lansoprazole in Barrett's Esophagus Patients
Status:
Completed
Trial end date:
2007-04-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to compare the treatment of esomeprazole 40 mg once daily and
lansoprazole 30 mg once daily in controlling intragastric pH in Barrett's Esophagus patients